Pathogenesis and Diagnostic Significance of EBV-miR-BARTs in Nasopharyngeal Carcinoma

Table 2

Comparison of cell proliferation rates in each group .

Grouping		Proliferation rate (%)
Control group	3
EBV-miR-BART5-3p NC group	3
EBV-miR-BART5-3p mimics group	3
EBV-miR-BART5-3p inhibitor group	3
		22.482
		<0.001

Note: Contrasted with the negative control group, .